Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

P50 Supplement: Improving Medications Adherence Equitably Among Patients With Metastatic Breast Cancer and Cardiovascular Disease

NCT06121453 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT06121453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06121453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
P50 Supplement: Improving Medications Adherence Equitably Among Patients With Metastatic Breast Cancer and Cardiovascular Disease
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Recruiting
Start date
April 12, 2024
Completion date
December 10, 2026
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer